Annual report [Section 13 and 15(d), not S-K Item 405]

Stock-Based Compensation (Tables)

v3.25.0.1
Stock-Based Compensation (Tables)
 12 Months Ended
Dec. 28, 2024
Share-Based Payment Arrangement, Noncash Expense [Abstract]  
Summary of Restricted Stock and RSU Activity

The following table summarizes RSU activity for the 2024 fiscal year:

 

 

Number of
Units
(in thousands)

 

 

Weighted Average
Grant-Date
Fair Value per Share

 

Nonvested balance at December 30, 2023

 

 

303

 

 

$

63.29

 

Granted

 

 

321

 

 

 

42.29

 

Vested

 

 

(178

)

 

 

55.69

 

Forfeited

 

 

(222

)

 

 

53.22

 

Nonvested balance at December 28, 2024

 

 

224

 

 

$

49.13

 

Included in the nonvested balance at December 28, 2024, is 70,117 nonvested performance-based RSUs.

Summary of Stock Options Granted Related to stock options, the Company recognized a net benefit of $1.6 for the year ended December 28, 2024 and an expense of $1.4 for the year ended December 30, 2023.

 

 

 

Number of
Shares
(not rounded)

 

 

Weighted Average
Exercise Price

 

Outstanding at December 30, 2023

 

 

92,233

 

 

$

49.97

 

Granted

 

 

36,502

 

 

 

40.13

 

Exercised

 

 

(8,366

)

 

 

36.86

 

Forfeited/Expired

 

 

(73,840

)

 

 

51.43

 

Outstanding at December 28, 2024

 

 

46,529

 

 

 

42.29

 

Exercisable at December 28, 2024 (A)

 

 

4,693

 

 

 

49.67

 

(A) Options expire between the years 2030-2032 with strike prices between $39.75 - $55.03.